T. Rowe Price Value has some promising traits, but a limited sample size makes them difficult to embrace.
T. Rowe Price Value TRVLX
- NAV / 1-Day Return 49.43 / +0.61 %
- Total Assets 30.9 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.710%
- Distribution Fee Level Below Average
- Share Class Type No Load
- Category Large Value
- Investment Style Large Value
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 1.11%
- Turnover 62%
USD | NAV as of Oct 04, 2024 | 1-Day Return as of Oct 04, 2024, 10:29 PM GMT+0
Morningstar’s Analysis TRVLX
Will TRVLX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 24.1
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Berkshire Hathaway Inc Class B | 3.78 | 1.2 Bil | Financial Services |
JPMorgan Chase & Co | 3.22 | 1.0 Bil | Financial Services |
Kenvue Inc | 2.76 | 859.7 Mil | Consumer Defensive |
Johnson & Johnson | 2.44 | 760.0 Mil | Healthcare |
UnitedHealth Group Inc | 2.28 | 710.0 Mil | Healthcare |
Elevance Health Inc | 2.22 | 692.6 Mil | Healthcare |
Bank of America Corp | 2.03 | 633.8 Mil | Financial Services |
AstraZeneca PLC ADR | 1.85 | 576.5 Mil | Healthcare |
Charles Schwab Corp | 1.75 | 544.0 Mil | Financial Services |
Fiserv Inc | 1.74 | 543.7 Mil | Technology |